Oxcarbazepine Suspension

Oxcarbazepine Suspension

Oxcarbazepine Suspension Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


Vinorelbine Injection, USP is indicated:

In combination with cisplatin for first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
As a single agent, for the treatment of patients with metastatic NSCLC


There is currently no drug history available for this drug.

Other Information

Vinorelbine Injection, USP is a semi-synthetic vinca alkaloid for intravenous injection. Chemically, vinorelbine tartrate is 3',4'-didehydro-4'-deoxy-C'-norvincaleukoblastine [R(R*,R*)-2, 3-dihydroxybutanedioate (1:2)(tartrate)] and has the following structure:



M.W. 1079.12.

Vinorelbine Injection, USP is a sterile nonpyrogeinc aqueous solution. Each vial contains vinorelbine tartrate equivalent to 10 mg (1-mL vial) or 50 mg (5-mL vial) vinorelbine in Water for Injection. The pH of Vinorelbine Injection, USP is approximately 3.5.

Oxcarbazepine Suspension Manufacturers

  • Roxane Laboratories, Inc
    Oxcarbazepine Suspension [Roxane Laboratories, Inc]
  • Ranbaxy Pharmaceuticals Inc.
    Oxcarbazepine Suspension [Ranbaxy Pharmaceuticals Inc. ]
  • Avkare, Inc.
    Oxcarbazepine Suspension [Avkare, Inc.]
  • Amneal Pharmaceuticals Of New York, Llc
    Oxcarbazepine Suspension [Amneal Pharmaceuticals Of New York, Llc]

Login To Your Free Account